2026/07/04 by Christopher Southan · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Chemical Reactions and Isotopes #PARP inhibition in cancer therapy #Protein Degradation and Inhibitors
paper · doi:10.59350/nxvkz-qy762
openalex publication_date 2026/07/04 · openalex created_date 2026/07/05 · openalex updated_date 2026/07/14
This session AACR (American Association for Cancer Research) 2026 Annual Meeting in San Diego included the first time disclosures of 11 oncology therapeutics, covering small and large molecule modalities as a first-look at the structures and preliminary data of novel cancer treatments that are entering or progressing through the clinic.